Aug 31 (Reuters) - CapVest Partners is nearing a deal to

acquire German drugmaker Stada Arzneimittel AG for about 10

billion euro ($11.7 billion) including debt, Bloomberg reported

on Sunday, citing people familiar with the matter.

The London-based buyout firm is finalizing terms of an

agreement with Stada's private equity owners Bain Capital and

Cinven, and a deal could be announced as soon as Monday, the

report added.

Reuters could not immediately verify the report.